Development of a predictive model for stromal content in prostate cancer samples to improve signature performance

Prostate cancer is heterogeneous in both cellular composition and patient outcome, and development of biomarker signatures to distinguish indolent from aggressive tumours is a high priority. Stroma plays an important role during prostate cancer progression and undergoes histological and transcriptio...

Descripción completa

Detalles Bibliográficos
Autores principales: Boufaied, Nadia, Takhar, Mandeep, Nash, Claire, Erho, Nicholas, Bismar, Tarek A, Davicioni, Elai, Thomson, Axel A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2019
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900085/
https://www.ncbi.nlm.nih.gov/pubmed/31206668
http://dx.doi.org/10.1002/path.5315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900085/
https://www.ncbi.nlm.nih.gov/pubmed/31206668
http://dx.doi.org/10.1002/path.5315

Ejemplares similares